Vawter Financial Ltd. Sells 50 Shares of Stryker Co. (NYSE:SYK)

Vawter Financial Ltd. lessened its position in shares of Stryker Co. (NYSE:SYK) by 2.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,972 shares of the medical technology company’s stock after selling 50 shares during the period. Vawter Financial Ltd.’s holdings in Stryker were worth $710,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Dunhill Financial LLC raised its stake in Stryker by 94.9% during the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock worth $27,000 after buying an additional 37 shares during the last quarter. Darwin Wealth Management LLC bought a new position in Stryker during the third quarter worth $36,000. Activest Wealth Management bought a new position in Stryker during the fourth quarter worth $36,000. Crews Bank & Trust bought a new stake in Stryker in the fourth quarter valued at $39,000. Finally, Hara Capital LLC bought a new stake in Stryker in the third quarter valued at $42,000. Institutional investors own 77.09% of the company’s stock.

Stryker Stock Up 0.1 %

Stryker stock opened at $385.44 on Wednesday. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The stock has a market cap of $147.08 billion, a PE ratio of 49.67, a price-to-earnings-growth ratio of 2.90 and a beta of 0.96. The firm’s 50-day simple moving average is $377.44 and its 200 day simple moving average is $367.94. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95.

Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter in the previous year, the firm earned $3.46 EPS. Research analysts predict that Stryker Co. will post 13.49 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date is Monday, March 31st. Stryker’s payout ratio is 43.30%.

Analyst Ratings Changes

SYK has been the subject of several research analyst reports. BTIG Research lifted their price target on shares of Stryker from $383.00 to $394.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Needham & Company LLC reaffirmed a “buy” rating and issued a $442.00 price target on shares of Stryker in a research note on Wednesday, January 29th. UBS Group lifted their price target on shares of Stryker from $366.00 to $370.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Stifel Nicolaus lifted their price target on shares of Stryker from $400.00 to $440.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. Finally, Barclays lifted their price target on shares of Stryker from $418.00 to $443.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $420.68.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 201,392 shares of the business’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the transaction, the director now directly owns 3,642,075 shares in the company, valued at $1,428,567,498. The trade was a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 5.50% of the company’s stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.